Strides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter

Sales rise 13.01% to Rs 1265.41 crore

Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1265.41	1119.74	13
OPM %	18.06	19.48	-
PBDT	192.82	179.30	8
PBT	136.42	130.41	5
NP	156.91	99.61	58

Powered by Capital Market - Live News